/usr/web/www.marshallindependent.com/wp-content/themes/coreV2/single.php
×

Pause on J&J COVID vaccine changes vaccine schedule for some area residents

CDC and FDA say they will investigate cases of rare blood clots in 6 women

MARSHALL — The Centers for Disease Control and the Food and Drug Administration are calling for a pause in using COVID-19 vaccines made by Johnson & Johnson, after six women developed blood clots.

On a local level, the recommendations mean some people will need to reschedule their COVID vaccine appointments. But vaccine providers in Marshall said they still have the capacity to give vaccines made by other manufacturers like Pfizer and Moderna.

Sandy Murphy, pharmacist at GuidePoint Pharmacy in Marshall, said GuidePoint is in the process of rescheduling COVID-19 vaccination clinics that were going to use the Johnson & Johnson vaccine.

“It’s a pretty rare side effect, but I’m glad they’re taking it seriously,” Murphy said of the blood clots the CDC and FDA are investigating.

GuidePoint had planned for about 100 people to receive the Johnson & Johnson COVID vaccine on Thursday, Murphy said. Those appointments will have to be rescheduled now. However, GuidePoint is still offering COVID-19 vaccination appointments using the Moderna vaccine, she said.

In a joint statement released Tuesday, representatives from the CDC and the FDA said they are reviewing data involving six cases of a “rare and severe” type of blood clot in people who had received the Johnson & Johnson COVID-19 vaccine. All six cases of blood clots occurred in women between the ages of 18 and 48, and symptoms of the blood clots appeared six to 13 days after the women had been vaccinated.

While the CDC and FDA investigate the blood clot cases, they are recommending a temporary pause in using the Johnson & Johnson vaccine, “out of an abundance of caution.”

Right now, these negative reactions to the Johnson & Johnson vaccine appear to be extremely rare, the CDC and FDA said. As of April 12, more than 6.8 million doses of the Johnson & Johnson vaccine have been given in the U.S., the joint statement said.

A state COVID-19 vaccination clinic held in Marshall earlier this spring used the Johnson & Johnson vaccine.

Several vaccine providers in the Marshall area said Tuesday that the pause on the Johnson & Johnson vaccine doesn’t mean that they’ll have to stop giving COVID-19 vaccines. Avera Marshall has mainly been using the Pfizer vaccine, and there is capacity for people to keep making vaccination appointments, said Avera Marshall Communications Partner Stacy Neubeck. Southwest Health and Human Services Public Health Director Carol Biren said the organization’s vaccine clinics in a six-county service area have used the Moderna vaccine. The Thrifty White and Hy-Vee pharmacies in Marshall also said they use the Pfizer and Moderna COVID vaccines, and are still receiving shipments.

Before the CDC and FDA’s recommendation this week, GuidePoint Pharmacy in Marshall had been offering both the Moderna and Johnson & Johnson COVID vaccines. Murphy said some area residents had been interested in the Johnson & Johnson vaccine because it involves only one shot, while the Pfizer and Moderna vaccines both require two doses.

“A lot of people still want to get vaccinated,” which is a positive thing, Murphy said.

While GuidePoint will have to reschedule its planned Johnson & Johnson vaccines for now, Murphy said the vaccine supply GuidePoint received won’t be wasted. The Johnson & Johnson vaccines can be stored longer than the Moderna vaccine, so there will potentially still be time left to administer them after the CDC and FDA finish their investigation, she said.

Newsletter

Today's breaking news and more in your inbox

Today's breaking news and more in your inbox
Are you a paying subscriber to the newspaper? *
   

Starting at $4.38/week.

Subscribe Today